Image 3_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 1_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

Image 4_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

“…</p>Results<p>G. vaginalis inoculated mice infected with HSV-2 had significantly decreased survival rates, increased pathology, and higher viral titers than PBS and L. crispatus inoculated mice. …”

<i>In vivo</i> treatment decreases bacterial burden and colonization of vital organs in a skin abscess biofilm infection model. by Robert L. Beckman I.V (22784303)

Map of Zimbabwe highlighting the districts detected as persistent hotspots of <i>S. haematobium</i> prevalence (PPHS), persistent hotspots of decreased praziquantel efficacy (EPHS)... by Takafira Mduluza (39754)

Overall cardiovascular disease 2^nd level risk factors rank ordered by attributed DALYs in 1990 and 2021 for females (above) and males (below) in Chile. Red. by Camilo Briones-Valdivieso (21567535)

Subjects:

Relative change in cardiovascular diseases DALYs rates from 1990-1994 to 2017-2021 in Chile, for both genders. by Camilo Briones-Valdivieso (21567535)

Subjects:

Cardiovascular diseases ranked by DALYs in 1990 and 2021 for females (above) and males (below) in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative cardiomyopathy and myocarditis DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative ischaemic heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative stroke DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative overall CVD DALYs rate attributable to 2^nd-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative aortic aneurysm DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects: